Pharmacy Updates Summary

Similar documents
Pharmacy Updates Summary

Relative Cost/Month. Less than $10. Loratadine Liquid* $10-$15 Cetirizine liquid 1mg/mL*

Drug Class Monograph

Inhaled Corticosteroids Drug Class Prior Authorization Protocol

A Visual Approach to Simplifying Respiratory Drug Regimens

Pharmacy Updates Summary

Inhaled Corticosteroids Drug Class Prior Authorization Protocol

A Visual Approach to Simplifying Respiratory Drug Regimens

A Visual Approach to Simplifying Respiratory Drug Regimens

Pharmacy Updates Summary

Quarterly pharmacy formulary change notice

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

MEDICAID QUANTITY LIMIT DRUG LIST

WVCH Formulary Additions Effective 01/01/2016 Name Strength Dosage Form Route Formulary Restrictions

Step Therapy Requirements

TRELEGY ELLIPTA (fluticasone-umeclidinium-vilanterol) aerosol powder

STEP THERAPY ALGORITHMS PUP Select Formulary

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

Quarterly pharmacy formulary change notice

PHOTOFRIN Porfimer ALL LOB: ADD NF PA FETZIMA Levomilnacipran 20-40mg Titration pack ALL LOB: Add NF with PA

Quarterly pharmacy formulary change

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice

The Medical Letter. on Drugs and Therapeutics

Step Therapy Requirements

2017 UnitedHealthcare Services, Inc.

REVISED RESPIRATORY MEDICATION USE QUESTIONNAIRE

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

AIRDUO RESPICLICK (fluticasone-salmeterol) aerosol DULERA (mometasone furoate and formoterol fumarate dihydrate) aerosol

Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria

APPENDIX 1 Printable point-of-care tables Asthma Action Plan Yellow Zone Formulation Table Region: Europe

Prescription benefit updates Large group

March 2017 Pharmacy & Therapeutics Committee Decisions

Correct Use of Inhaler Devices

ACYCLOVIR OINT (CCHP2017)

Select Inhaled Respiratory Agents

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Drug Effectiveness Review Project Summary Report

Alprazolam 0.25mg, 0.5mg, 1mg tablets

Ferris State University College of Pharmacy MPA CE Symposium 2016 Paul Thill, PharmD, BCPS

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

2017 United Healthcare Services, Inc.

Peach State Health Plan routinely reviews the medications available on the Preferred Drug

EXECUTIVE SUMMARY. Uniform Formulary (UF) Beneficiary Advisory Panel (BAP) Comments 31 July 2014

Umpqua Health Alliance (OHP) Formulary Changes January 2018

UPDATE Ohana QUEST Integration Medicaid

Clinical Policy: Roflumilast (Daliresp) Reference Number: CP.PMN.46 Effective Date: Last Review Date: 08.18

TABLE OF CONTENTS (Click on a link below to view the section.)

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 07/05/18 SECTION: DRUGS LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:

II. UF CLASS REVIEWS NASAL ALLERGY DRUGS

Quarterly pharmacy formulary change notice

ALLERGIC RHINITIS-NASAL

Oregon Health Plan prescription benefit updates

COPD Medications Coverage Summary Non-Insured Health Benefits Coverage SABA Bricanyl turbuhaler Yes Yes

Quarterly pharmacy formulary change notice

Proton Pump Inhibitors

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

Performance Drug List Change Summary Report Effective (Standard Drug List Reflects Removals)

Calgary Long Term Care Formulary. Pharmacy & Therapeutics. February 2015

ACYCLOVIR OINT (CCHP2017)

Quarterly pharmacy formulary change notice

DEPARTMENT OF DEFENSE PHARMACY AND THERAPEUTICS COMMITTEE RECOMMENDATIONS INFORMATION FOR THE UNIFORM FORMULARY BENEFICIARY ADVISORY PANEL

ACYCLOVIR OINT (CCHP2017)

2014 Quantity Limits (QL) Criteria

Additional Drug Coverage

Impact of a Comprehensive COPD Therapeutic Interchange Program on 30-Day Readmission Rates in Hospitalized Patients

BRINTELLIX. Step Therapy Criteria HealthTeam Advantage Formulary ID: Version 6 Effective Date: 1/1/2016. PRODUCT(s) AFFECTED BRINTELLIX

FASENRA (benralizumab)

ARBS MEDICATION(S) SUBJECT TO STEP THERAPY DIOVAN HCT MG TAB, DIOVAN HCT MG TABLET

PHARMA-MEDIC SERVICES INC. POLICY MANUAL

See Important Reminder at the end of this policy for important regulatory and legal information.

2015 Chinese Community Health Plan Senior Program (HMO) Step Therapy Criteria Last Updated 11/1/2015

Your prescription benefit updates Formulary Updates - Effective January 1, 2019

Pharmacy and Therapeutics Committee-approved Therapeutic Interchange

Key features and changes to these four components of asthma care include:

MEDICATION COVERAGE POLICY PHARMACY AND THERAPEUTICS ADVISORY COMMITTEE POLICY: Asthma/COPD P&T DATE 12/14/2017 CLASS:

STRIVERDI RESPIMAT (olodaterol hcl) aerosol

EFFECTIVE 01/04/2019. pimecrolimus 1 % cream (g) - Added to Tier 1 - ST Added: TOPICAL IMMUNOMODULATORS

Diagnosis and Management of Asthma

BYSTOLIC. Products Affected Step 2: BYSTOLIC 10 MG TABLET BYSTOLIC 2.5 MG TABLET. Details BYSTOLIC 20 MG TABLET BYSTOLIC 5 MG TABLET

MARSHALLTOWN MEDICAL & SURGICAL CENTER Marshalltown, Iowa

HEALTHTEAM ADVANTAGE PLAN 2017 Step Therapy Criteria Pending CMS Approval

Aetna Better Health of Illinois Medicaid Formulary Updates

Plan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST)

Tabletki Glucophage 500 Mg

AGGRENOX. Products Affected. Details. Open 1 Last Updated: 10/01/2018. Aggrenox

2018 Step Therapy Criteria

End Stage COPD Guidance Document

PA Start Date Therapeutic Class P&T Review Date 7/1/13 TOP$ (Single Drug Reviews) include:

Prescription benefit updates Individual/small group

Non-members present from Catamaran: Leslie Pittman, PharmD, Tracey Lovett, PharmD

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Health Choice Generations 1 Tier Gold Effective Date: 11/01/2018.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Optima Tier Gold Formulary Date Effective: November 1, 2018.

Step Therapy Requirements. Effective: 12/01/2016

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009

List of Designated High-Cost Drugs

ATYPICAL ANTIPSYCHOTICS

Transcription:

All of the following changes were reviewed and approved by the SFHP Pharmacy & Therapeutics (P&T) Committee on 7/16/2014 Effective date: 8/15/2014 Therapeutic Classes reviewed: Hepatitis C Ophthalmic Prostaglandins Asthma/COPD Prior Authorization Criteria Updates Ophthalmic Prostaglandins Advair Diskus and Advair HFA TNF Alpha inhibitors Hepatitis C Proton Pump Inhibitors Policies/Forms Approved New: Pharm-12 Enteral Nutrition Products Revised: Pharm-01 Pharmacy and Therapeutics Committee

Approved Changes: Hepatitis C Drug Class Boceprevir (Victrelis ) 200 mg Ribapak 600 400 mg tab, 200 400 mg tab Ribavirin 400 mg tab 600 mg tab Simeprevir (Olysio ) 150 mg PA required PA required Sofosbuvir (Sovaldi ) 400 mg PA required PA required Telaprevir (Incivek ) 375 mg PA required PA required Ophthalmic Prostaglandins Drug Class Bimatoprost (Lumigan ) Latanoprost (Xalatan ) Travoprost (Travatan Z ) 21 y/o 21 y/o

Asthma/COPD Travoprost (Travatan ) ST with latanoprost; 21 y/o ST with latanoprost; 21 y/o Indacaterol (Arcapta Neohaler) Mometasone (Asmanex) Aclidinium (Tudorza Pressair) Ciclesonide (Alvesco) Budesonide/Formoterol (Symbicort) Fluticasone/Salmeterol (Advair Diskus Advair HFA) Mometasone/Formoterol (Dulera) Roflumilast (Daliresp) QL of #2 per 30 QL of #1 per 30 QL of 10.2 per 30 Non for 12 y/o; for 4-11 y/o QL of 13 per 30 QL of #2 per 30 QL of #1 per 30 QL of 10.2 per 30 Non for 12 y/o; for 4-11 y/o QL of 13 per 30

Proposed Changes Drug Name Medi-Cal Healthy Kids CWRAP Lorazepam QL #3 per day QL #3 per day No changes 0.5, 1, 2 mg Glycerin Excluded (OTC) suppositories Salicylic acid 17% liquid QL #15 per 30 Excluded (OTC) QL #15 per 30 Salicylic acid /Flex Collodion Liquid QL #14.8 per 30 Excluded (OTC) QL #14.8 per 30 Vitamin B-12 (Cyanocobalamin) 1,000 mcg IR Capscaicin 0.1% cream Estradiol Valerate 20mg/Ml, 10mg/Ml, 40mg/Ml Alprazolam ER ODT, 1 mg/ml solution Metformin ER 750 mg (Glucophage XR) Armour Thyroid 15mg 30mg Excluded (OTC) #42.5 grams per 30 Excluded (OTC) #42.5 grams per 30 #10 per 80 #10 per 80 No changes Excluded #2 per day #2 per day No changes, min age 21 y/o, min age 21 y/o No changes

60mg 90mg 120mg 180mg 240mg 300mg ASA/APAP/Caffeine 250 250-65mg (Excedrin) APAP/Caffeine 500-65mg (Excedrin) Isometheptene/ Dichloralphenazone/ Acetaminophen (Midrin) Isometheptene/ Caffeine/ Acetaminophen (Prodrin) Desmopressin 0.1, 0.2 mg tabs Bupropion SR 150 mg (Zyban) Bupropion XL 450 mg (Forfivo XL) Dexlansoprazole 30 mg, 60 mg (Dexilant ) Excluded (OTC) Excluded (OTC) Excluded Excluded 0.1 mg #1 per day 0.1 mg #1 per day No changes 0.2 mg #3 per day, age 7-18 0.2 mg #3 per day, age 7-18 Esomeprazole Magnesium Step therapy QL #2/day Excluded (OTC) Step therapy QL

(Nexium 24HR-OTC) Esomeprazole (Nexium ) 20 mg, 40 mg Terbinafine 250 mg tabs (Lamisil) Fish oil 1000 mg caps, 1000 mg softgel caps Levofloxacin 250, 500, 750 mg Anakinra (Kineret ) Abatacept (Orencia ) Ustekinumab (Stelara ) Tofacitinib Citrate (Xeljanz ) *changes effective 8/15/14 CWRAP = Medicare/Medi-Cal (pantoprazole AND omeprazole) #2/day (pantoprazole AND omeprazole) No changes without without grandfathering grandfathering #90 per 365 #90 per 365 No changes #120 per 30 Excluded (OTC) #120 per 30 #30 per 30 #30 per 30 No changes